MedPath

A Weight-Neutral Approach for a Healthier Lifestyle Among Obesity - A Lifestyle Intervention Anchored in SDOI

Not Applicable
Conditions
Health Related Quality of Life and Weight Condition
Registration Number
NCT05708417
Lead Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Brief Summary

The study aim is to evaluate a patient-centred intervention focusing on improved quality of life and wellbeing among individuals with obesity and risk factors for adverse outcome.

Detailed Description

In Denmark, University Hospital of Southern Denmark in Esbjerg has initiated The South Danish Obesity Initiative (SDOI) to optimize the treatment of and the research in obesity. The hospital has for years, offered treatment to individuals with obesity, however, SDOI is an investigation program with the aim to identify people with undiagnosed obesity-related diseases by a systematic and stepwise approach, delivering an up-to-date treatment of diagnosed diseases and offering personalized lifestyle advice based on the finding in the investigation program. The SDOI program comprises collaboration between different medical departments at the hospital and furthermore, entails the establishment of a well-defined cohort as a basis for research. ACT is of interest in the construction of the personalized lifestyle advice in the SDOI program. However, there is limited research available on the effect of the behaviour therapy ACT as a basic method for a lifestyle program targeting overweight individuals who have been made aware of obesity related diseases and re-conditions. ACT might be a valuable tool to assist these individuals to increase their quality of life and thereby, ability to make lifestyle changes.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Participants will be eligible for inclusion if they are ≥18 years
  • Body mass index above 30 kg/m2
Exclusion Criteria
  • Individuals referred for bariatric surgery will not be eligible for inclusion in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HRQoL .52 weeks

Measured by the questionnaire Impact of Weight on Quality of Life-Lite at week 52. Scores range from 0 to 100, with 100 representing the best quality of life.

Secondary Outcome Measures
NameTimeMethod
Self-esteem52 weeks

Measured by questionnaire

General physical activity52 weeks

Measured by Accelerometer

Isometric muscle strength52 weeks

Measured by Biodex dynanometer

Aerobic capacity52 weeks

One-point Åstrand test

Body perception52 weeks

Questionnaire

Total cholesterol (mml/L)52 weeks

Blood sample

Diastolic and systolic Blood pressure (mm Hg)52 weeks

Blood pressure monitor

Insulin resistance (HOMA-IR)52 weeks

Blood sample

Perceived chronic pain52 weeks

Measured on VAS scale. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100

Trial Locations

Locations (1)

Hospital of Southwest Denmark

🇩🇰

Esbjerg, Region Of Southern Denmark, Denmark

Hospital of Southwest Denmark
🇩🇰Esbjerg, Region Of Southern Denmark, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.